Jim Buck

Jim joined ClearCut in April 2019 after more than twenty-five years of experience successfully developing and commercializing innovative medical technologies. Prior to joining ClearCut, Jim served as President & CEO of Mardil Medical, a privately funded early-stage developer of an implantable device system platform addressing structural heart disease conditions; President & CEO, SetPoint Medical; VP, marketing & business development at InnerPulse, a privately funded developer of a novel implantable defibrillator system; and VP, marketing & business development at Closure Medical, leading the product mapping strategy and execution for a breakthrough surgical sealant and adhesive technology culminating in a $370 million acquisition and integration into Johnson & Johnson where Jim then served as VP of strategy within the biologicals division.

Previous to Closure Medical/J&J, Jim held several positions of increasingly greater responsibility in strategic and product marketing and corporate development over eleven years at cardiac medical device leader St. Jude Medical (now Abbott). Jim holds a master of management from Northwestern University’s Kellogg Graduate School of management and a bachelor’s degree from Indiana University. Jim resides with his wife Lisa and four children in Orono, Minnesota, USA